article thumbnail

Biotechnology and Today's Warfighter

The Rand Blog

Biotechnology has a broad and often misunderstood scope, one with significant implications for today's warfighter, and it may be reaching a critical junction.

article thumbnail

Bill of Health’s Top 10 Posts of 2022

Bill of Health

We look forward to continuing our coverage of key issues in health law policy, biotechnology, and bioethics in 2023. By Chloe Reichel. As 2022 draws to a close, we’re looking back at the top ten most-read articles published on Bill of Health this year. Browse the list below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In Academia, Innovators Receive Unfair Compensation for Their Discoveries

Bill Of Health

Biotechnology Intellectual Property Matt Bauer Research Funding patents universitiesBy Matt Bauer. In academia, many of the scientists who are recognized as inventors on patents see little economic gain from these agreements.

article thumbnail

Decolonizing the Pandemic Treaty Through Vaccine Equity

Bill Of Health

By Tlaleng Mofokeng, Daniel Wainstock, and Renzo Guinto. In recent years, there have been growing calls to “ decolonize ” the field of global health.

article thumbnail

We All Stand to Benefit from Biden’s $2 Billion Bet on the Bioeconomy

Bill of Health

Business is bustling for biotechnology and biomanufacturing. On September 12, 2022, President Biden signed an executive order , launching a “whole-of-government approach to advance biotechnology and biomanufacturing.” Biotechnology regulation. By Matthew Chun.

article thumbnail

The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good 

Bill Of Health

By Ellen ‘t Hoen. The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis.

article thumbnail

Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021

Bill of Health

By Matthew Chun With its leadership in drug development , biotechnology , and computing technologies , the United States touts itself as being “ the most innovative economy in the world.” biotechnology, President Biden also recognized that “ fundamental R&D of emerging biotechnologies.

article thumbnail

Promoting Vaccine Equity

Bill Of Health

By Ana Santos Rutschman. The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines against emerging pathogens.

article thumbnail

Does It Really Matter How the COVID-19 Pandemic Started?

Bill of Health

By Barbara Pfeffer Billauer Throughout the COVID-19 pandemic, much air time and social media space has been allocated to the lab leak vs. natural spillover dispute regarding the origins of SARS-CoV-2.

article thumbnail

Leverage COVID-19 Frameworks to Prepare for the Next Pandemic

Bill Of Health

Biotechnology Health Law Policy International Pharmaceuticals Public Health Research Funding Resource Allocation Vaccines COVID covid boosters covid pandemic infectious disease infectious disease surveillance mers pandemic preparedness pandemic prevention pandemic response sars SARS-CoV-2

article thumbnail

The Not-So-Sacred Human Genome: What South Africans Think About Heritable Human Genome Editing

Bill of Health

Bioethics Biotechnology Enhancement Genetics International Personhood AIDS Gene editing heritable human genome editing HIV HIV/AIDS human genome human genome editing south africa tb tuberculosisBy Donrich Thaldar.

article thumbnail

The International Weaponization of Health Data

Bill of Health

By Matthew Chun. International collaboration through the sharing of health data is crucial for advancing human health. But it also comes with risks — risks that countries around the world seem increasingly unwilling to take.

article thumbnail

The ‘Res Nullius’ Construction of Human Genomic Data

Bill of Health

Biotechnology Genetics Intellectual Property International Privacy data genomic data property law res nulliusBy Donrich Thaldar. No one domain of the law holds exclusive sway over human genomic data.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

IBM and Google) to biotechnology (e.g., Biotechnology Featured Health Law Policy Intellectual Property Jorge Contreras Public Health Vaccines compulsory licensing COVID-19 covid-19 vaccine Health Resources moderna Open COVID pledge patent Patent Law patent pledge patentsBy Jorge L.

article thumbnail

A New Theory for Gene Ownership

Bill of Health

Without her knowledge or consent, her doctors derived from the cells the HeLa cell line — the world’s first immortal human cell line, worth billions and a driver of the biotechnology revolution. By James Toomey.

Doctors 87
article thumbnail

Book Review: ‘Drugs and the FDA: Safety, Efficacy, and the Public’s Trust’ by Mikkael A. Sekeres

Bill of Health

Bioethics Biotechnology FDA FDA in the 21st Century Conference Matthew Chun Medical Safety Pharmaceuticals access to medicine Book Review drug law drug regulation Patient autonomy pharmaceuticalBy Matthew Chun.

article thumbnail

Another Legislative Attempt to Revive Gene Patenting

Bill of Health

Not surprisingly, some representatives of the biotechnology industry, and many patent lawyers, reacted negatively to the decision, and have steadily lobbied Congress to restore patent protection for isolated and purified genomic sequences. Biotechnology Gene Editing Genetics Jorge Contreras

article thumbnail

Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?

Bill of Health

Biotechnology Global Health Intellectual Property International Pharmaceuticals Public Health Race Resource Allocation Sarah Gabriele Student Fellows Vaccines africa biontech COVID covid pandemic covid-19 vaccines global vaccine inequity know-how moderna vaccine equityBy Sarah Gabriele.

article thumbnail

AI in Digital Health: Autonomy, Governance, and Privacy

Bill of Health

Artificial Intelligence Biotechnology Digital Health Health Information Technology Medical devices Patient Care Privacy Publications AI algorithms data privacy EthicsThe following post is adapted from the edited volume AI in eHealth: Human Autonomy, Data Governance and Privacy in Healthcare.

article thumbnail

Mainstreaming Reproductive Genetic Innovation

Bill of Health

By Myrisha S. Lewis. Despite religious and ethical objections, assisted reproductive technology (ART), including in vitro fertilization and egg freezing, manages to flourish in the United States, with some states and companies even creating regimes for its insurance coverage.

article thumbnail

Pig Hearts for Humans and the FDA

Bill of Health

Animal Research Biotechnology FDA Health Law Policy Organs Public Health Resource Allocation Organ Transplantation organ transplants xenotransplantationBy Jacob Balamut.

article thumbnail

Reclaiming Global Public Health

Bill of Health

By Zain Rizvi. By December 2020, the world had astonishingly powerful tools against COVID-19. New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators.

article thumbnail

The Legality of Pandemic Detection and Prevention Technology

Bill Of Health

Biotechnology Global Health Health Law Policy Public Health Scientific Evidence commerce clause coronavirus pandemic COVID-19 covid-19 pandemic COVID19 isolation medical isolation laws novel pathogens pandemic detection pandemic prevention pathogens quaratine Tenth Amendment test-and-isolate

article thumbnail

COVID-19, Patents, and Trade Secrets

Bill of Health

Biotechnology Intellectual Property Pharmaceuticals Vaccines covid vaccine covid-19 vaccine IP moderna moderna covid vaccine moderna covid-19 vaccine patent Pfizer trade secretBy David Gindler & Jasper L. Has the worldwide distribution of COVID-19 vaccines been impacted by patent rights?

article thumbnail

Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’

Bill of Health

This problem is not new in the biotechnology sector. By Aparajita Lath.

article thumbnail

Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?

Bill of Health

Biotechnology Featured Genetics Health Information Technology History Intellectual Property Jorge Contreras Research Funding Scientific Evidence Supreme Court Vaccines aclu Association for Molecular Pathology v. By Jorge L. Contreras.

article thumbnail

A Response to ‘Another Legislative Attempt to Revive Gene Patenting’

Bill of Health

Myriad Genetics could boost investment in biotechnology R&D. Biotechnological innovations also face resource-intensive and risky development cycles. Biotechnology Gene Editing Genetics Pharmaceuticals Supreme Court Association for Molecular Pathology v.

article thumbnail

COVID ‘Compromise’ on International IP Underscores Need for New Approach

Bill of Health

By Cynthia M.

article thumbnail

Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA

Bill of Health

For example, while a biotechnology company might be incentivized to claim the similarity of its products to already approved products to benefit from expedited FDA clearance (e.g., By Matthew Chun.

article thumbnail

The Risk of Pervasive Trade Secret Practices Within the Life Sciences

Bill of Health

Biotechnology Health Law Policy Intellectual Property Matt Bauer biologics Biosimilars patents Trade SecretsBy Matt Bauer.

article thumbnail

The Journal of Law and the Biosciences’ Growing Impact

Bill of Health

Announcements Bioethics Biotechnology Health Law Policy Petrie-Flom Center Public Health Abortion choice of law dobbs Dobbs v.

article thumbnail

Lessons Learned from the COVID-19 Pandemic: The Future for Diagnostics

Bill of Health

Biotechnology CRISPR Matt Bauer Medical devices Public Health COVID-19 diagnostic tests Diagnostics mCARMEN pandemic pandemic diagnostics pcr rapid antigen testsBy Matthew Bauer and Nicole Welch. Diagnostic tests have changed in the eyes of many Americans across the COVID-19 pandemic.

article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. By Sapna Kumar and Ana Santos Rutschman.

article thumbnail

Call for Submissions: Journal of Law and the Biosciences Special Issue on Abortion Law

Bill Of Health

Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.

article thumbnail

Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic

Bill Of Health

By Brook K. Baker .

article thumbnail

The Civil Rights Challenge to Gene Patenting

Bill Of Health

Myriad Genetics that naturally occurring DNA sequences are not patentable, a ruling that has had repercussions throughout the scientific community and the biotechnology industry. Register now for tomorrow’s discussion of The Genome Defense ! By Jorge L. Contreras.

article thumbnail

Call for Submissions: Journal of Law and the Biosciences Special Issue on Abortion Law

Bill of Health

Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.

article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians.

article thumbnail

Vevo Launches with $12M to Scale Vivo Data Generation to Discover Better Drugs

HIT Consultant

What You Should Know: – Vevo Therapeutics , an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.

article thumbnail

Biotech R&D Platform Benchling Closes $100M at $6B Valuation

HIT Consultant

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. Biotechnology is rewriting life as we know it.

article thumbnail

JPMorgan Establishes Life Sciences Private Equity Division

HIT Consultant

What You Should Know: – J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital.

article thumbnail

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

HIT Consultant

Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, and cancer, and advance research in tissue engineering and regenerative medicine.

article thumbnail

CareMetx Acquires Patient Adherence Platform Human Care Systems

HIT Consultant

HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. What You Should Know: – Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products.